<?xml version='1.0' encoding='utf-8'?>
<document id="25352873"><sentence text="In vitro evidence for bakuchiol's influence towards drug metabolism through inhibition of UDP-glucuronosyltransferase (UGT) 2B7." /><sentence text="Inhibition of drug-metabolizing enzymes (DMEs) has been regarded as one of the most important reason for clinical drug-drug interaction" /><sentence text="" /><sentence text="The aim of the present study is to evaluate the inhibition of bakuchiol towards UDP-glucuronosyltransferase (UGT) 2B isoforms"><entity charOffset="62-71" id="DDI-PubMed.25352873.s4.e0" text="bakuchiol" /></sentence><sentence text="" /><sentence text="In vitro recombinant UGT2B-catalyzed 4-methylumbelliferone glucuronidation was used as the probe reaction"><entity charOffset="37-58" id="DDI-PubMed.25352873.s6.e0" text="4-methylumbelliferone" /></sentence><sentence text=" Dixon plot and Lineweaver-Burk plot were employed to determine the inhibition kinetic type, and nonlinear regression of data was utilized to calculate the inhibition kinetic parameter (Ki)" /><sentence text=" In vitro-in vivo extrapolation (IVIVE) was carried out to predict in vivo inhibition magnitude" /><sentence text="" /><sentence text="Among the tested UGT2B isoforms, UGT2B7 was inhibited by the strongest intensity" /><sentence text=" The noncompetitive inhibition was demonstrated by the results obtained from Dixon plot and Lineweaver-Burk plot" /><sentence text=" The Ki value was calculated to be 10" /><sentence text="7 ÂµM" /><sentence text=" In combination with the reported concentration after an intravenous administration of bakuchiol (15 mg/kg) in rats, the high risk of in vivo inhibition of bakuchiol towards UGT2B7-catalyzed metabolism of drugs was indicated"><entity charOffset="87-96" id="DDI-PubMed.25352873.s14.e0" text="bakuchiol" /><entity charOffset="156-165" id="DDI-PubMed.25352873.s14.e1" text="bakuchiol" /><pair ddi="false" e1="DDI-PubMed.25352873.s14.e0" e2="DDI-PubMed.25352873.s14.e0" /><pair ddi="false" e1="DDI-PubMed.25352873.s14.e0" e2="DDI-PubMed.25352873.s14.e1" /></sentence><sentence text="" /><sentence text="All these results provide an important information for the risk evaluation of the clinical utilization of bakuchiol"><entity charOffset="106-115" id="DDI-PubMed.25352873.s16.e0" text="bakuchiol" /></sentence><sentence text="" /></document>